Viral Vector Characterization and Analytical Development
September 25 to September 27, 2023
Hilton Boston/Woburn, 2 Forbes Road, Woburn, Massachusetts, 01801, United States
The Viral Vector Characterization & Analytical Development Summit in 2023 marks a pivotal moment in the industry as it witnesses a renaissance in viral vector characterization. With increased complexity and the need for precision, this summit brings together industry leaders in characterization, analytical development, formulation, and quality to optimize process development and accelerate vector scale-up. Join top companies such as Ultragenyx, Kite Pharma, and Pfizer for a 3-day agenda tackling the biggest bottlenecks in this rapidly evolving field. Stay ahead of the curve and seize cross-learning opportunities to benchmark your work and transform workflows.
The Cardiomyopathy and Cardio-Oncology Symposium is designed to provide a state-of-the-art, comprehensive curriculum that addresses important clinical topics relevant to cardiomyopathy and the cardiovascular health of cancer patients and survivors. Cardio-oncology is an important and emerging field of medicine resulting from new or unexpected cardiovascular toxicities many cancer survivors are now experiencing because of their cancer treatments. In addition, cardiac amyloidosis is a burgeoning disease with exciting new treatments. Nationally recognized faculty in the fields of cardiology and oncology will discuss challenging topics related to common cardiomyopathies as well as current best practices for diagnosing, treating and managing afflicted patients. The goal of the conference is for participants to return to their practice equipped with the latest evidence base and practical information to improve patient care.
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our